Insulet Corporation (PODD)
Healthcare • Medical Devices
StockNasdaqGSUnited StatesUS45784P1012
150.40 USD
+0.74% today Updated 13 Nov 2026 15:34
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Insulet Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:34. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
17 Feb 2027
in 96 days · 08:00 · estimate 1.75
Last results
1.99 vs 1.59 estimated
04 Nov 2026 · Beat +25.4%
Beat the estimate
11 of 12
1 missed · 0 in line · 9 beats in a row
Average surprise
+29.5%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 17 Feb 2027 08:00 | 1.75 | — | — | Upcoming |
| 04 Nov 2026 07:00 | 1.59 | 1.99 | +25.4% | Beat |
| 05 Aug 2026 07:00 | 1.45 | 1.66 | +14.3% | Beat |
| 06 May 2026 07:00 | 1.19 | 1.42 | +19.3% | Beat |
| 18 Feb 2026 07:00 | 1.46 | 1.55 | +6.0% | Beat |
| 06 Nov 2025 06:00 | 1.15 | 1.24 | +8.1% | Beat |
| 07 Aug 2025 07:00 | 0.92 | 1.17 | +26.8% | Beat |
| 08 May 2025 16:00 | 0.79 | 1.02 | +29.7% | Beat |
| 20 Feb 2025 16:00 | 1.02 | 1.15 | +12.6% | Beat |
| 07 Nov 2024 16:00 | 0.76 | 0.90 | +18.3% | Beat |
| 08 Aug 2024 16:00 | 0.56 | 0.55 | -2.5% | Miss |
| 09 May 2024 16:00 | 0.39 | 0.73 | +85.1% | Beat |
| 22 Feb 2024 16:00 | 0.66 | 1.40 | +111.4% | Beat |
| 02 Nov 2023 16:00 | 0.41 | 0.71 | +73.8% | Beat |
| 08 Aug 2023 16:00 | 0.26 | 0.38 | +43.4% | Beat |
| 04 May 2023 16:00 | 0.10 | 0.23 | +122.2% | Beat |
| 23 Feb 2023 16:00 | 0.19 | 0.55 | +188.9% | Beat |
| 03 Nov 2022 16:00 | 0.14 | 0.41 | +194.3% | Beat |
| 04 Aug 2022 16:00 | 0.23 | -0.08 | -133.6% | Miss |
| 05 May 2022 16:00 | 0.24 | 0.40 | +68.2% | Beat |
| 23 Feb 2022 16:00 | 0.33 | 0.43 | +29.0% | Beat |
| 04 Nov 2021 16:00 | 0.25 | 0.20 | -20.8% | Miss |
| 05 Aug 2021 16:00 | 0.14 | 0.15 | +13.8% | Beat |
| 06 May 2021 16:00 | 0.09 | — | -100.0% | — |
| 23 Feb 2021 16:00 | -0.02 | -0.05 | -137.2% | Miss |
| 04 Nov 2020 16:00 | 0.08 | 0.17 | +116.1% | Beat |
| 06 Aug 2020 16:00 | 0.01 | 0.22 | +1,898.2% | Beat |
| 07 May 2020 17:00 | -0.02 | -0.03 | -94.2% | Miss |
| 25 Feb 2020 16:00 | 0.12 | 0.10 | -15.1% | Miss |
| 05 Nov 2019 16:00 | 0.04 | 0.09 | +111.0% | Beat |
| 05 Aug 2019 16:00 | 0.03 | 0.02 | -30.1% | Miss |
| 02 May 2019 16:00 | 0.01 | 0.07 | +396.1% | Beat |
| 25 Feb 2019 16:00 | 0.06 | 0.16 | +167.9% | Beat |
| 01 Nov 2018 16:00 | 0.03 | 0.03 | -6.3% | Miss |
| 02 Aug 2018 16:00 | -0.13 | -0.03 | +76.5% | Beat |
| 03 May 2018 16:00 | -0.18 | -0.11 | +39.7% | Beat |
| 21 Feb 2018 16:00 | -0.08 | -0.12 | -53.6% | Miss |
| 02 Nov 2017 16:00 | -0.10 | -0.04 | +60.2% | Beat |
| 03 Aug 2017 16:00 | -0.12 | -0.13 | -5.6% | Miss |
| 08 May 2017 16:00 | -0.15 | -0.17 | -10.7% | Miss |
| 27 Feb 2017 16:00 | -0.06 | -0.16 | -155.2% | Miss |
| 03 Nov 2016 16:00 | -0.08 | -0.01 | +89.3% | Beat |
| 03 Aug 2016 16:00 | -0.17 | -0.08 | +54.4% | Beat |
| 28 Apr 2016 16:00 | -0.22 | -0.19 | +12.8% | Beat |
| 25 Feb 2016 16:00 | -0.26 | -0.27 | -2.1% | Miss |
| 05 Nov 2015 16:00 | -0.26 | -0.20 | +23.4% | Beat |
| 12 Aug 2015 16:00 | -0.11 | -0.22 | -95.9% | Miss |
| 30 Apr 2015 16:00 | -0.12 | -0.19 | -58.8% | Miss |
| 26 Feb 2015 16:00 | -0.02 | -0.03 | -50.0% | Miss |
| 05 Nov 2014 16:00 | -0.01 | — | +100.0% | — |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 2.7B | +30.7% | 247.1M | 9.1% | 3.48 | -39.8% | 349.9M |
| 2024 | 2.1B | +22.1% | 418.3M | 20.2% | 5.78 | +96.6% | 296.2M |
| 2023 | 1.7B | +30.0% | 206.3M | 12.2% | 2.94 | +4,100.0% | 36.5M |
| 2022 | 1.3B | — | 4.6M | 0.4% | 0.07 | — | -38.3M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 150.22 | 168.47 | 143.28 | 150.40 | +0.48% | 13,272,904 | |
| Oct 2026 | 131.78 | 154.95 | 128.01 | 149.68 | +14.72% | 34,096,800 | |
| Sep 2026 | 149.79 | 151.50 | 130.10 | 130.47 | -12.24% | 31,665,200 | |
| Aug 2026 | 168.56 | 172.11 | 126.40 | 148.66 | -10.09% | 42,592,000 | |
| Jul 2026 | 157.69 | 172.92 | 152.78 | 165.35 | +8.60% | 28,453,800 | |
| Jun 2026 | 146.51 | 161.35 | 138.79 | 152.25 | +5.04% | 33,402,700 | |
| May 2026 | 174.19 | 178.04 | 140.63 | 144.94 | -15.80% | 35,700,800 | |
| Apr 2026 | 210.18 | 212.72 | 158.35 | 172.14 | -17.97% | 22,630,800 | |
| Mar 2026 | 243.99 | 249.23 | 205.11 | 209.84 | -14.91% | 21,512,800 | |
| Feb 2026 | 256.91 | 275.10 | 237.02 | 246.61 | -3.60% | 22,071,400 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Insulet (PODD) Just Overtook the 20-Day Moving Average (opens in a new tab) Zacks · 12 Nov 2026 13:35
- Insulet: Rivals Are Building Patch Pumps, But Insulet Already Owns The Pharmacy Counter (opens in a new tab) SeekingAlpha · 11 Nov 2026 11:39
- Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes" (opens in a new tab) Zacks · 10 Nov 2026 19:42
- For World Diabetes Day, Insulet Launches "Give Yourself the Freedom to" Campaign, Encouraging People with Diabetes to Prioritize Their Well-Being (opens in a new tab) 09 Nov 2026 12:00
- Truist Securities Reiterates Hold on Insulet, Raises Price Target to $160 (opens in a new tab) Benzinga · 09 Nov 2026 10:11
- Barclays Maintains Equal-Weight on Insulet, Raises Price Target to $165 (opens in a new tab) Benzinga · 06 Nov 2026 12:13
- Insulet (PODD) Stock May Be 36% Undervalued Despite $1b Buyback (opens in a new tab) Simply Wall St. · 05 Nov 2026 23:20
- UBS Maintains Neutral on Insulet, Raises Price Target to $171 (opens in a new tab) Benzinga · 05 Nov 2026 20:41
- JP Morgan Maintains Neutral on Insulet, Raises Price Target to $170 (opens in a new tab) Benzinga · 05 Nov 2026 19:31
- Citigroup Maintains Neutral on Insulet, Raises Price Target to $170 (opens in a new tab) Benzinga · 05 Nov 2026 18:07
- Leerink Partners Maintains Market Perform on Insulet, Raises Price Target to $167 (opens in a new tab) Benzinga · 05 Nov 2026 16:01
- RBC Capital Maintains Outperform on Insulet, Raises Price Target to $180 (opens in a new tab) Benzinga · 05 Nov 2026 15:29
- Bernstein Maintains Outperform on Insulet, Raises Price Target to $200 (opens in a new tab) Benzinga · 05 Nov 2026 13:22
- Wells Fargo Maintains Equal-Weight on Insulet, Raises Price Target to $172 (opens in a new tab) Benzinga · 05 Nov 2026 11:16
- Insulet Stock What’s Changed After Earnings Beat (opens in a new tab) Simply Wall St. · 05 Nov 2026 05:24
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 149.29 USD
- Market cap
- 10.5B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Devices
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow PODD and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.